These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 12734721)
1. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Stratov I; Korman TM; Johnson PD Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):277-83. PubMed ID: 12734721 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of calcium sulfate and hydroxyapatite antifungal disks loaded with amphotericin B or voriconazole in consideration for adjunctive osteomyelitis management. Karr JC; Lauretta J J Am Podiatr Med Assoc; 2015 Mar; 105(2):104-10. PubMed ID: 25815648 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia. Lassaletta A; Perez A; Díaz MA; Sevilla J; González-Vicent M; Madero L J Pediatr Hematol Oncol; 2004 Feb; 26(2):117-9. PubMed ID: 14767202 [No Abstract] [Full Text] [Related]
5. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis. Kirkpatrick WR; Coco BJ; Patterson TF Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887 [TBL] [Abstract][Full Text] [Related]
6. Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature. Nicolle A; de la Blanchardière A; Bonhomme J; Hamon M; Leclercq R; Hitier M Infection; 2013 Aug; 41(4):833-40. PubMed ID: 23625788 [TBL] [Abstract][Full Text] [Related]
7. Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease. Rösen-Wolff A; Koch A; Friedrich W; Hahn G; Gahr M; Roesler J Pediatr Infect Dis J; 2004 Jun; 23(6):584-6. PubMed ID: 15194848 [TBL] [Abstract][Full Text] [Related]
8. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Panicker J; Walsh T; Kamani N Pediatr Infect Dis J; 2006 Apr; 25(4):377-9. PubMed ID: 16567998 [TBL] [Abstract][Full Text] [Related]
9. Two cases of cerebral aspergillosis successfully treated with voriconazole. de Lastours V; Lefort A; Zappa M; Dufour V; Belmatoug N; Fantin B Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):297-9. PubMed ID: 12740666 [TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole. Craiglow B; Hinds G; Antaya R; Girardi M Pediatr Dermatol; 2009; 26(4):493-5. PubMed ID: 19689543 [TBL] [Abstract][Full Text] [Related]
11. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience. Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324 [TBL] [Abstract][Full Text] [Related]
12. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed. Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210 [TBL] [Abstract][Full Text] [Related]
13. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment. Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314 [TBL] [Abstract][Full Text] [Related]
14. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review. Parize P; Chandesris MO; Lanternier F; Poirée S; Viard JP; Bienvenu B; Mimoun M; Méchai F; Mamzer MF; Herman P; Bougnoux ME; Lecuit M; Lortholary O Antimicrob Agents Chemother; 2009 Mar; 53(3):1048-53. PubMed ID: 19104029 [TBL] [Abstract][Full Text] [Related]
15. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia. Shouldice E; Fernandez C; McCully B; Schmidt M; Fraser R; Cook C J Pediatr Hematol Oncol; 2003 Sep; 25(9):732-4. PubMed ID: 12972810 [TBL] [Abstract][Full Text] [Related]
16. Treatment of invasive infections due to rare or emerging yeasts and moulds. Sahin GO; Akova M Expert Opin Pharmacother; 2006 Jun; 7(9):1181-90. PubMed ID: 16732704 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Kaya AD; Kiraz N Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704 [TBL] [Abstract][Full Text] [Related]
18. Aspergillus vertebral osteomyelitis and epidural abscess. Tew CW; Han FC; Jureen R; Tey BH Singapore Med J; 2009 Apr; 50(4):e151-4. PubMed ID: 19421672 [TBL] [Abstract][Full Text] [Related]
19. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy]. Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628 [TBL] [Abstract][Full Text] [Related]